Instil Bio, Inc.
TIL
$28.41
$2.7010.50%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 29.33% | 36.72% | 52.50% | 61.85% | 35.64% |
| Total Depreciation and Amortization | -45.62% | -21.60% | -24.10% | -32.89% | -41.85% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -23.16% | -34.03% | -64.97% | -77.48% | 8.38% |
| Change in Net Operating Assets | -1,619.57% | -219.52% | -39.81% | 29.41% | 109.63% |
| Cash from Operations | 5.93% | 26.33% | 32.10% | 44.60% | 60.01% |
| Capital Expenditure | -- | -- | -- | 99.83% | 90.28% |
| Sale of Property, Plant, and Equipment | -64.59% | -18.37% | -44.38% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.81% | 14.18% | -11.83% | -43.50% | -70.34% |
| Cash from Investing | 12.28% | 51.61% | 31.23% | -8.43% | -54.92% |
| Total Debt Issued | -- | 1,937.13% | 887.43% | -100.00% | -100.00% |
| Total Debt Repaid | -14,012.10% | -14,012.10% | -14,012.10% | 100.00% | -- |
| Issuance of Common Stock | -- | -- | -- | -57.71% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1,576.83% | -45.03% | -78.29% | -98.89% | -101.98% |
| Foreign Exchange rate Adjustments | 123.43% | 105.00% | 53.23% | 57.14% | 70.34% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 106.55% | 148.10% | 99.82% | 88.93% | 19.43% |